Stockreport

Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019

Virpax Pharmaceuticals, Inc.  (VRPX) 
PDF --  Company to Pursue Prophylactic Treatment Against SARS and Influenza for Daily Use as an OTC Product -- BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. [Read more]